Trusted by:

clients clients clients clients clients clients clients clients clients clients
Released: 29-Jan-2014 10:00 AM EST
Said the Tumor to Its Neighbor, “You’ve Got Mail”
University of Kansas Cancer Center

Aside from the 2013 Nobel Prize in Medicine going to the discoverers of this highly organized transport system, scientific interest in a particular group of vesicles called exosomes has accelerated over the last several years. Andrew K. Godwin, Ph.D., professor and director of molecular oncology at the University of Kansas Medical Center, is among the researchers studying the potential clinical applications of these specialized structures.

Released: 10-Feb-2014 10:00 AM EST
Researchers Establish Benefits of High-Dose Vitamin C for Ovarian Cancer Patients
University of Kansas Cancer Center

Researchers at the University of Kansas Medical Center found that a combination of infused vitamin C and conventional chemotherapy stopped ovarian cancer in the laboratory, and reduced chemotherapy-associated toxicity in patients with ovarian cancer.

Released: 19-Mar-2014 2:00 PM EDT
APC and Colon Cancer: Location Matters
University of Kansas Cancer Center

Adenomatous polyposis coli is critical in protecting against colon cancer. KU Cancer Center researchers have shown that APC stationed in the nucleus is necessary to suppress Wnt and its signaling partners.

Released: 2-Apr-2014 10:00 AM EDT
Cell-Surface Receptor Offers Promising Breakthrough for Pancreatic Cancer Patients
University of Kansas Cancer Center

Findings provide a direct proof for a new therapy and provide hope for the people with this disease

Released: 20-Jun-2014 3:30 PM EDT
Starving Pancreatic Cancer Before It Has a Chance to Feast
University of Kansas Cancer Center

KU Cancer Center researchers are working towards cutting off the growth of pancreatic tumors before they can metastasize throughout the body.

Released: 4-Aug-2014 11:00 AM EDT
Clinical Trial Shows Promising Results for Late-Stage Cancer Patients
University of Kansas Cancer Center

KU Cancer Center Nanotex Phase I trial extends survival rate and is better tolerated for ovarian and other abdominal cancer patients.

Released: 9-Sep-2014 11:15 AM EDT
Genetic Modifier Impacts Colon Tumor Formation
University of Kansas Cancer Center

Unexpected results from an ongoing experiment in the lab of Kristi Neufeld, Ph.D., co-leader of the Cancer Biology Program, led to a potentially important discovery that could have an impact on how cancer researchers test anti-cancer therapies in mice, and possibly prevent colon cancer in people.

Released: 29-Oct-2014 11:00 AM EDT
Researchers Identify Potential Target for Treating Triple-Negative Breast Cancer
University of Kansas Cancer Center

KU Cancer Center researchers have identified a protein that could prevent metastasis and recurrence of breast cancer.

   
Released: 1-Dec-2014 11:00 AM EST
Innovative “Tumor in a Dish” Turns Cells Into Cancer
University of Kansas Cancer Center

New research technique could allow better, more personalized cancer drug treatments

   
Released: 5-Jan-2015 2:00 PM EST
Complex Math Model Could Be Simple Way to Predict Bladder Cancer Recurrence
University of Kansas Cancer Center

Statistical prediction models could help doctors determine when non-invasive bladder cancer will return.


close
2.29174